A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis

Strijbos, E.; Huijbers, M.G.; Es, I.E. van; Alleman, I.; Ostaijen-ten Dam, M.M. van; Bakker, J.; ... ; Verschuuren, J.J. (2017)

Article / Letter to editor

• Tetanus
• Vaccination
• Autoimmune disease
• Myasthenia gravis
• Immunosuppression
• Antibodies

• All authors: Strijbos, E.; Huijbers, M.G.; Es, I.E. van; Alleman, I.; Ostaijen-ten Dam, M.M. van; Bakker, J.; Zwet, E.W. van; Jol-van der Zijde, C.M.; Tol, M.D. van; Verschuuren, J.J.
• Date: 2017-11-01
• Journal: Vaccine
• Volume: 35
• Issue: 46
• Pages: 6290 - 6296
• DOI: doi:10.1016/j.vaccine.2017.09.078